What does DR.PIETER VANSINTJAN do?

DR.PIETER VANSINTJAN is a specialist medical practice in Gent. Private Limited, started on 27 February 2020, 1 establishment.

What is the address of DR.PIETER VANSINTJAN?

The registered office of DR.PIETER VANSINTJAN is located at Ottergemsesteenweg 412, 9000 Gent.

Is DR.PIETER VANSINTJAN still active?

Yes. According to the CBE (29 October 2026) DR.PIETER VANSINTJAN is active, legal situation “Normale toestand”, started on 27 February 2020.

Is DR.PIETER VANSINTJAN registered on Peppol?

Yes, DR.PIETER VANSINTJAN is registered on the Peppol network with ID 0208:0744504791.

What is the enterprise number of DR.PIETER VANSINTJAN?

The enterprise number of DR.PIETER VANSINTJAN is BE0744504791.

When was DR.PIETER VANSINTJAN founded?

DR.PIETER VANSINTJAN was founded on 27 February 2020.

Who are the directors of DR.PIETER VANSINTJAN?

According to the 2026 annual accounts, the directors of DR.PIETER VANSINTJAN are: Pieter Vansintjan.

Is DR.PIETER VANSINTJAN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 February 2020; 5 annual accounts filed, latest fiscal year 2026; 1 directors known from the annual account.

How much profit did DR.PIETER VANSINTJAN make in 2026?

DR.PIETER VANSINTJAN posted a profit after taxes of € 277,789 in financial year 2026.

What is the revenue of DR.PIETER VANSINTJAN?

As a small company, DR.PIETER VANSINTJAN is not required to publish revenue in its annual accounts. In financial year 2026, its added value was € 451,284.

DR.PIETER VANSINTJAN (Private Limited) - Gent

Dossier DR.PIETER VANSINTJAN, printed on 29 October 2026 from databakkes.be/en/0744504791/dr-pieter-vansintjan. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2026

DR.PIETER VANSINTJAN from Gent, company number BE0744504791, closed financial year 2026 with a result of € 277,789 after tax. For that financial year DR.PIETER VANSINTJAN recorded a gross margin of € 451,284 and equity of € 939,849. Compared with financial year 2025, the result moved from € 236,088 to € 277,789. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 9, 2026.

What it is worth Growing

€ 939,849

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 277,789

▲ 18% vs 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 307,057

▲ 111% vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 275,746 paid out

99 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2026

Vehicles and equipment

€ 1,064

▼ 28% vs 2025

Book value of vehicles, furniture and equipment.

Debts at end 2026

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 289,548

▼ 17% vs 2025

€ 60,265 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 26,678

▲ € 20,542 vs 2025

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 250

▼ 99% vs 2025

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	2026	Change 2025 → 2026
Gross margin	€ 278,481 Gross margin 2023: € 278,481 First fiscal year in the series	€ 475,189 Gross margin 2024: € 475,189 ▲ 71% vs 2023 (€ 278,481) Favourable step	€ 390,057 Gross margin 2025: € 390,057 ▼ 18% vs 2024 (€ 475,189) Unfavourable step	€ 451,284 Gross margin 2026: € 451,284 ▲ 16% vs 2025 (€ 390,057) Favourable step	▲ 16%
Profit after taxes	€ 142,401 Profit after taxes 2023: € 142,401 First fiscal year in the series	€ 281,838 Profit after taxes 2024: € 281,838 ▲ 98% vs 2023 (€ 142,401) Favourable step	€ 236,088 Profit after taxes 2025: € 236,088 ▼ 16% vs 2024 (€ 281,838) Unfavourable step	€ 277,789 Profit after taxes 2026: € 277,789 ▲ 18% vs 2025 (€ 236,088) Favourable step	▲ 18%
Equity	€ 421,513 Equity 2023: € 421,513 First fiscal year in the series	€ 702,552 Equity 2024: € 702,552 ▲ 67% vs 2023 (€ 421,513) Favourable step	€ 937,806 Equity 2025: € 937,806 ▲ 33% vs 2024 (€ 702,552) Favourable step	€ 939,849 Equity 2026: € 939,849 Unchanged (€ 937,806) Favourable step
Total debts	€ 527,542 Total debts 2023: € 527,542 First fiscal year in the series	€ 539,975 Total debts 2024: € 539,975 ▲ 2% vs 2023 (€ 527,542) Unfavourable step	€ 392,612 Total debts 2025: € 392,612 ▼ 27% vs 2024 (€ 539,975) Favourable step	€ 319,298 Total debts 2026: € 319,298 ▼ 19% vs 2025 (€ 392,612) Favourable step	▼ 19%
Cash	€ 522,080 Cash 2023: € 522,080 First fiscal year in the series	€ 228,039 Cash 2024: € 228,039 ▼ 56% vs 2023 (€ 522,080) Unfavourable step	€ 145,384 Cash 2025: € 145,384 ▼ 36% vs 2024 (€ 228,039) Unfavourable step	€ 307,057 Cash 2026: € 307,057 ▲ 111% vs 2025 (€ 145,384) Favourable step	▲ 111%
Retained profit	€ 416,513 Retained profit 2023: € 416,513 First fiscal year in the series	€ 697,552 Retained profit 2024: € 697,552 ▲ 67% vs 2023 (€ 416,513) Favourable step	€ 932,806 Retained profit 2025: € 932,806 ▲ 34% vs 2024 (€ 697,552) Favourable step	€ 934,849 Retained profit 2026: € 934,849 Unchanged (€ 932,806) Favourable step
Dividend	€ 800 Dividend 2023: € 800 First fiscal year in the series	€ 800 Dividend 2024: € 800 Unchanged (€ 800) Unchanged	€ 833 Dividend 2025: € 833 ▲ 4% vs 2024 (€ 800) Unchanged	€ 275,746 Dividend 2026: € 275,746 ▲ € 274,913 vs 2025 (€ 833) Unchanged	▲ € 274,913
Bank debt	€ 468,152 Bank debt 2023: € 468,152 First fiscal year in the series	€ 408,983 Bank debt 2024: € 408,983 ▼ 13% vs 2023 (€ 468,152) Favourable step	€ 349,447 Bank debt 2025: € 349,447 ▼ 15% vs 2024 (€ 408,983) Favourable step	€ 289,548 Bank debt 2026: € 289,548 ▼ 17% vs 2025 (€ 349,447) Favourable step	▼ 17%
Balance sheet total	€ 949,055 Balance sheet total 2023: € 949,055 First fiscal year in the series	€ 1,242,527 Balance sheet total 2024: € 1,242,527 ▲ 31% vs 2023 (€ 949,055) Unchanged	€ 1,330,418 Balance sheet total 2025: € 1,330,418 ▲ 7% vs 2024 (€ 1,242,527) Unchanged	€ 1,259,148 Balance sheet total 2026: € 1,259,148 ▼ 5% vs 2025 (€ 1,330,418) Unchanged	▼ 5%

Key figures of DR.PIETER VANSINTJAN, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.

What happened to DR.PIETER VANSINTJAN?

What happened at DR.PIETER VANSINTJAN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 9, 2026 New annual accounts for financial year 2026: profit of € 277,789 (▲ 18% vs 2025). Source: NBB ↗
Feb 27, 2020 New establishment in Gent. KBO
2020 Pieter Vansintjan became a director. NBB
Feb 27, 2020 Start of the company according to the CBE. KBO

In short

From € 142,401 profit in 2023 to € 277,789 profit in 2026.

Paid € 418,200 in corporate taxes since 2023.

Best year ever: 2024, with € 281,838 profit.

Paid out € 278,179 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Pieter Vansintjan

DR.PIETER VANSINTJAN

MOG BV 33.3%

Behind DR.PIETER VANSINTJAN is Pieter Vansintjan. It owns 33.3% of MOG BV itself.

Directors

According to the 2026 annual accounts

Pieter Vansintjan

Director

Also active at: MOG, CoMedZ

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Ottergemsesteenweg 412

9000 Gent

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0744.504.791
VAT number: BE 0744.504.791
Registered office: Ottergemsesteenweg 412, 9000 Gent
Names & denominations: DR.PIETER VANSINTJAN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 27 February 2020
Peppol: Active · Active since 11 Sept 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗